atrasentan has been researched along with Heart Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abdelhady, SA; Darwish, IE; El-Deeb, NM; El-Mas, MM; Gowayed, MA; Habib, YH | 1 |
Kang, JJ; Kang, PM; Ke, Q; Kim, UK; Samad, MA | 1 |
2 other study(ies) available for atrasentan and Heart Diseases
Article | Year |
---|---|
Prenatal endothelin or thromboxane receptor antagonism surpasses sympathoinhibition in improving cardiorenal malfunctions in preeclamptic rats.
Topics: Animals; Atrasentan; Endothelin A Receptor Antagonists; Female; Gene Expression Regulation; Heart Diseases; Hemodynamics; Kidney; Kidney Diseases; Myocardium; Naphthalenes; Pre-Eclampsia; Pregnancy; Propionates; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Thromboxane A2, Prostaglandin H2 | 2021 |
Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.
Topics: Animals; Atrasentan; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Disease Models, Animal; Echocardiography; Endothelin A Receptor Antagonists; Gene Expression; Heart Diseases; Hemodynamics; Hypertension; Hypertrophy; Kidney Function Tests; Male; Myocytes, Cardiac; Phenylephrine; Pyrrolidines; Rats; Receptor, Endothelin A; Renal Insufficiency, Chronic | 2015 |